Starry Gene

Hefei, China · Founded 2019 · Privately Held (backing)

Developer of genetic modification technologies intended for therapeutic applications in ophthalmic disorders. Starry Gene is based in Hefei, China and was founded in 2019. Its last reported valuation was $11.9 million in Nov 2020. It has raised $4.5 million.

Last reported valuation

$11.9M

Oct 2026

Priced at

—

Total raised

$4.5M

Last round

—

How much has Starry Gene raised?

$4.5Macross 0 recorded rounds

Free account

More of Starry Gene with a free account

·Watch Starry Gene: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Starry Gene investors

10 investors are on record for Starry Gene, including CAS Star, Hefei Industry Investment Group, Hefei Innovation Technology Venture Capital and Hefei Hi-Tech VC.

For fundraisers

Raising for a company like Starry Gene?

10 investors have backed Starry Gene.

See all 10 investors →

Frequently asked about Starry Gene

How much has Starry Gene raised?: Starry Gene has raised $4.5M in total across 0 recorded funding rounds.